The Effect of Pre-incisional Local Xylocaine Injection on Post Operative Pain and Scar Formation After Cesarean Section

Sponsor
The Baruch Padeh Medical Center, Poriya (Other)
Overall Status
Unknown status
CT.gov ID
NCT00914498
Collaborator
(none)
120
1
2

Study Details

Study Description

Brief Summary

This study will examine whether pre-incision infiltration of the skin cut site can attenuate post operative pain after a cesarean section. One hundred and twenty women will be allocated to get 20 ml of either placebo or 1% xylocaine at the site of skin incision. We will also examine possible effect of this infiltration of parameters of wound heeling and scar formation, six weeks post partum.

Condition or Disease Intervention/Treatment Phase
  • Drug: Local, pre-incisional injection of 20 ml 1% xylocaine
N/A

Detailed Description

Among all other abdominal operations cesarean section is unique in two aspects. First, the requirement for rapid and as painless as possible recovery is not only important for the general good reasons, but there is the newborn baby, who needs maternal care. Second, in many cases the operation recurs in the same site, which may involve higher level of post operative pain.

Application of local anesthetics to the incision site have been tried for abdominal operation in several forms, ranging from pre-incision injection (1-6) through post incision injection (7 ) to indwelling catheter for protracted instillation (8-9). Where tried, these methods mostly contributed to the reduction of post operative pain and patients' satisfaction, although there is no consensus as to its efficacy. Yet, local, pre-incision injection of local anesthetics has not been tested for cesarean section.

The above not withstanding, it has been proposed that local infiltration of tissue with xylocaine may interfere with wound healing (10-11). Others suggested possible benefit due to antimicrobial activity (12) Conversely, Al- Asfour et al. (13) found no effect of topical oral application of xylocaine on experimental wounds in rabbits. Interestingly, Drucker et al. found that less collagen was deposited in healing wounds that were infiltrated with xylocaine prior to incision, while the strength of the scar was not affected (14-15).

Our proposed study will examine whether pre-incision infiltration of the skin cut site can attenuate post operative pain after a cesarean section. It will also examine possible effect of this infiltration of parameters of wound heeling and scar formation.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
120 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
The Effect of Pre-incisional Local Xylocaine Injection on Post Operative Pain and Scar Formation After Cesarean Section
Study Start Date :
Jul 1, 2009
Anticipated Primary Completion Date :
Dec 1, 2010

Arms and Interventions

Arm Intervention/Treatment
Experimental: Xylocaine

Participants will receive local injection of 20 ml 1% Xylocaine to the skin incision site

Drug: Local, pre-incisional injection of 20 ml 1% xylocaine
Local, pre-incisional injection of 20 ml 1% xylocaine

Placebo Comparator: Controls

Participants will receive injection of 0.9% NaCl 20 ml to the incision site

Drug: Local, pre-incisional injection of 20 ml 1% xylocaine
Local, pre-incisional injection of 20 ml 1% xylocaine

Outcome Measures

Primary Outcome Measures

  1. Level of post operative pain on a visual analog scale [Up to 48 hours postoperative]

Secondary Outcome Measures

  1. Appearance of operative scar, compared to previous scar [6-8 weeks]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 45 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Candidates for non-emergency cesarean section
Exclusion Criteria:
  • Emergency cesarean section

  • Known or suspected sensitivity to local anesthetics

  • Pre-eclamptic toxemia

  • Deranged liver function

  • Deranged hemostasis

  • Lack of adequate verbal communication

Contacts and Locations

Locations

Site City State Country Postal Code
1 Department of Obstetrics & Gynecology, Baruch Padeh Medical Center Poriya Israel

Sponsors and Collaborators

  • The Baruch Padeh Medical Center, Poriya

Investigators

  • Principal Investigator: Izhar Ben-Shlomo, MD, Department of Obstetrics & Gynecology, Baruch Padeh Medical Center

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00914498
Other Study ID Numbers:
  • Xylocaine CS Scar.CTIL
First Posted:
Jun 5, 2009
Last Update Posted:
Aug 25, 2009
Last Verified:
Aug 1, 2009
Keywords provided by , ,
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 25, 2009